Adherence to a healthier, anti-inflammatory diet was associated with a reduced risk for all-cause mortality among patients with RA.
Certain metabolic factors are associated with the development of chronic musculoskeletal pain, including higher BMI and the presence of diabetes.
Pediatric patients who adopted and sustained a CD exclusion diet achieved clinical remission and reported improvement in clinical symptoms and fecal calprotectin.
Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.
Contemporary estrogen-progestin contraceptives are associated with an increased risk for ischemic stroke and myocardial infarction.
A recent study finds that women with epilepsy may have offspring with decreased bone metabolism and lower birth weight.
The US FDA has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy.